Luminex Sales Rise 14 Percent in Q2 | GenomeWeb

NEW YORK (GenomeWeb news) – Luminex reported after the close of the market Thursday that its second-quarter 2009 revenues increased 14 percent, and it turned a net loss into a profit when compared with the same period in 2008.

The Austin, Texas-based molecular diagnostics instrumentation and assay maker had revenues of $27.8 million for the three-month period ended June 30, compared to revenues of $24.3 million for the second quarter last year. Analysts, on average, had expected revenues of $29.9 million for Q2 2009.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: RNA-seq, ChIP-seq to determine metformin response; array-based approach to detect protozoa in blood; and more.

Fast Company takes a look at startups in the nutrigenomic space that aim to offer personalized diet advice.

In a glamorous event, the Breakthrough Foundation gave out more than $25 million in prizes to researchers.

Immunotherapy might treat cancer, but it also appears to come with a risk of a number of side effects, the New York Times reports.